Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment

In this volume of The Journal, Lioger et  al report on a systematic review comparing the efficacy and safety of anti-D immunoglobulin (anti-D) and intravenous immunoglobulin (IVIG) in the treatment of pediatric immune thrombocytopenia (ITP).1 The methodology of the authors is meticulous, and this work clearly highlights the significant ga ps in evidence that persist in the management of ITP despite the fact that it is one of the most common diseases encountered in pediatric hematology. The authors performed a search for randomized controlled trials that enrolled children
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Editorials Source Type: research